Peter Thiel Joins Board of Directors of AbCellera
Summary
AbCellera, a Vancouver, British Columbia, Canada-based technology company that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease, appointed Peter Thiel to its Board of Directors. Commenting on the announcement, Carl Hansen, Ph.D., CEO of AbCellera, said: “Peter has been a valued AbCellera investor and brings deep experience in scaling global technology companies.” He added: “We share his optimistic vision for the future, faith in technological progress, and long-term view on company building. We’re excited to have him join our board and look forward to working with him over the coming years.” Mr. Thiel is a technology entrepreneur, investor, and author. Outside of business, Mr. Thiel is a regular public speaker on topics of technology and economics and has taught a series of lectures on startup companies at Stanford. AbCellera’s technology, which combines high-throughput microfluidics, hyper-scale data science, machine learning, bioinformatics, and genomics, identifies new drug candidates and aims to reduce the time it takes to bring treatments to the clinic.